To explore the impact of NUPR1+ macrophages on immunotherapy outcomes, tumor tissues were collected from patients with HCC undergoing PD‐1 blockade at Zhongshan Hospital, affiliated to Fudan University (Figure7A). Here, NUPR1 is linked to hepatocellular carcinoma.